weekly chemotherapy with cyclophosphamide 80 mg m-2 day-1 p.o . continuously , methotrexate 35 mg m-2 week-1 i.v. , 5-fluorouracil 500 mg m-2 week-1 i.v. , vincristine 1.4 mg m-2 i.v . every two weeks and prednisolone 20 mg m-2 day-1 p.o . continuously ( cmfvp ) was prospectively studied in 45 previously untreated outpatients with advanced breast cancer to determine the feasibility of delivering a dose-intense regimen .
C0016360
fluorouracil
C0055987
cmfvp